Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9283 USD | -1.58% | +2.55% | +10.71% |
May. 09 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
May. 09 | X4 Pharmaceuticals Receives $125 Million Additional Capital; Shares Rise | MT |
Business Summary
Number of employees: 116
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paula Ragan
FOU | Founder | 54 | 14-06-30 |
Adam Mostafa
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Mary DiBiase
COO | Chief Operating Officer | 63 | 16-12-31 |
Chief Tech/Sci/R&D Officer | - | 23-07-31 | |
Art Taveras
CTO | Chief Tech/Sci/R&D Officer | 60 | 20-11-01 |
Murray Stewart
BRD | Director/Board Member | 63 | 19-03-28 |
Brian Bowersox
PRN | Corporate Officer/Principal | - | - |
Mark Baldry
PRN | Corporate Officer/Principal | 60 | 22-11-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 18-06-30 |
David McGirr
BRD | Director/Board Member | 69 | 17-08-31 |
Paula Ragan
FOU | Founder | 54 | 14-06-30 |
Gary Bridger
BRD | Director/Board Member | 61 | 18-09-30 |
Alison Lawton
BRD | Director/Board Member | 62 | 20-10-04 |
Bill Aliski
BRD | Director/Board Member | 75 | 19-09-17 |
Director/Board Member | 62 | 21-10-13 | |
Murray Stewart
BRD | Director/Board Member | 63 | 19-03-28 |
R. Woods
BRD | Director/Board Member | 57 | 23-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 167,937,781 | 162,820,401 ( 96.95 %) | 0 | 96.95 % |
Company contact information
X4 Pharmaceuticals, Inc.
61 North Beacon Street 4th floor
02134, Boston
+857 529 8300
http://www.x4pharma.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.71% | 158M | |
+8.38% | 115B | |
+10.13% | 105B | |
-11.69% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-16.00% | 16.01B | |
+2.28% | 14.14B | |
+20.54% | 10.71B |
- Stock Market
- Equities
- XFOR Stock
- Company X4 Pharmaceuticals, Inc.